SPC227

Emicizumab

  • Status:
    Veitt
  • Application date:
    24.5.2018
  • Application published:
    15.6.2018
  • Grant published:
    15.11.2019
  • Max expiry date:
    26.8.2033
  • Medicine name:
    Hemlibra
  • Medicine for children:
    Yes

Timeline

Today
24.5.2018Application
15.6.2018Publication
15.11.2019Registration
26.8.2033Expires

Marketing license

  • IS authorization number:
    EU/1/18/1271/001-004
  • Date:
    2.3.2018
  • Foreign authorization number:
    EU/1/18/1271
  • Date:
    23.2.2018

Owner

  • Name:
    Chugai Seiyaku Kabushiki Kaisha
  • Address:
    5-1, Ukima 5-chome, Kita-ku Tokyo JP

Agent

  • Name:
    Örn Þór slf.
  • Address:
    Klukkuvöllum 17, 221 Hafnarfirði

Patent

Deadlines

TypeDeadline until

Type: Formgallafrestur, fyrsti

Deadline until: 20.12.2023

Upload documents